Brain Aging: Clinical Trials

2 trials for Brain Aging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1

Follow Brain Aging: new trials by email Literature Review of Brain Aging trials Research Report on Brain Aging

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
AKG and Brain Health in Aging
Calcium AKG, Oral placebo capsules - Brain Aging, Cerebrovascular Function
Phase 2Not yet recruitingUniversity of Oklahoma602027-02-012026-10-06
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older Adults
Alpha-Linolenic Acid (2.6 g/day), Placebo Control Group - Cognitive Dysfunction, Alzheimer Disease
Phase 2RecruitingMichal Schnaider Beeri, Ph.D.202025-01-122026-02-06

Narrower conditions

Alzheimer Disease (1)  ·  Apolipoprotein E, Deficiency or Defect of (1)  ·  Cognitive Dysfunction (1)  ·  Nerve Degeneration (1)

Broader conditions

Brain Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cognition Disorders (1)  ·  Dementia (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurocognitive Disorders (1)  ·  Neurodegenerative Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Tauopathies (1)

Interventions

Corn Oil (1)  ·  Linseed Oil (1)  ·  alpha-Linolenic Acid (1)

Sponsors

Michal Schnaider Beeri, Ph.D. (1)  ·  University of Oklahoma (1)

Countries

United States (1)

Top investigators

Andriy Yabluchanskiy, MD, PhD (1)  ·  Michal Beeri, PHD (1)

NIH funding

R21AG103782 (1)